Template:Dgfn2015 So 13:00 Mittagssymposium Nr.2, ..ANCA assoziierte Vaskulitiden
From HOP house of papers
(Difference between revisions)
Ossip Groth (Talk | contribs) |
Ossip Groth (Talk | contribs) |
||
Line 1: | Line 1: | ||
==So 13:00 Mittagssymposium Nr.2, ..ANCA assoziierte Vaskulitiden== | ==So 13:00 Mittagssymposium Nr.2, ..ANCA assoziierte Vaskulitiden== | ||
− | === | + | ===Update zur Diagnostik ANCA-assoziierter Vaskulitiden=== |
− | [http://nephrologie.conference2web.com/users/ | + | [http://nephrologie.conference2web.com/users/7715 Fleck-M] |
− | + | ||
{{tp|p=23045170|t=2013. 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides |pdf=http://onlinelibrary.wiley.com/doi/10.1002/art.37715/pdf|usr=}} | {{tp|p=23045170|t=2013. 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides |pdf=http://onlinelibrary.wiley.com/doi/10.1002/art.37715/pdf|usr=}} | ||
{{slink|l=http://onlinelibrary.wiley.com/doi/10.1002/art.v33:8/issuetoc|t=1990 ARA Claasification Issue 33(8), AR}} | {{slink|l=http://onlinelibrary.wiley.com/doi/10.1002/art.v33:8/issuetoc|t=1990 ARA Claasification Issue 33(8), AR}} | ||
{{tp|p=20862686|t=2011. Improved outcome in 445 patients with Wegener s granulomatosis in a German vasculitis center over four decades |pdf=http://onlinelibrary.wiley.com/doi/10.1002/art.27763/pdf|usr=}} | {{tp|p=20862686|t=2011. Improved outcome in 445 patients with Wegener s granulomatosis in a German vasculitis center over four decades |pdf=http://onlinelibrary.wiley.com/doi/10.1002/art.27763/pdf|usr=}} | ||
− | + | {{tp|p=26297628|t=2015. Clinical presentation and long-term outcome of 144 patients with microscopic polyangiitis in a monocentric German cohort |pdf=http://rheumatology.oxfordjournals.org/content/early/2015/08/19/rheumatology.kev286.full.pdf+html|usr=}} | |
− | + | internist 2016 56 41 holle submitted | |
===Aktuelle Leitlinien und Ausblicke zur Therapie ANCA-assoziierter Vaskulitiden mit Rituximab=== | ===Aktuelle Leitlinien und Ausblicke zur Therapie ANCA-assoziierter Vaskulitiden mit Rituximab=== | ||
Line 92: | Line 91: | ||
{{utp|p=24703438|t=2014. Rituximab for induction and maintenance therapy in granulomatosis with polyangiitis (Wegener s) Results of a single-center cohort study on 66 patients |pdf=http://www.sciencedirect.com/science/article/pii/S0896841114000663|usr=}} | {{utp|p=24703438|t=2014. Rituximab for induction and maintenance therapy in granulomatosis with polyangiitis (Wegener s) Results of a single-center cohort study on 66 patients |pdf=http://www.sciencedirect.com/science/article/pii/S0896841114000663|usr=}} | ||
− | |||
− | |||
− | |||
− |
Latest revision as of 21:04, 27 September 2015
Contents |
So 13:00 Mittagssymposium Nr.2, ..ANCA assoziierte Vaskulitiden
Update zur Diagnostik ANCA-assoziierter Vaskulitiden
Journal article, free access |
GET 2013. 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides Extract PDF direct |
Weblink noncommercial {{{c}}} |
1990 ARA Claasification Issue 33(8), AR |
Journal article, free access |
GET 2011. Improved outcome in 445 patients with Wegener s granulomatosis in a German vasculitis center over four decades Extract PDF direct |
Journal article, free access |
GET 2015. Clinical presentation and long-term outcome of 144 patients with microscopic polyangiitis in a monocentric German cohort Extract PDF direct |
internist 2016 56 41 holle submitted
Aktuelle Leitlinien und Ausblicke zur Therapie ANCA-assoziierter Vaskulitiden mit Rituximab
??Brock et al.
Journal article, free access |
GET 2009. A multicenter survey of rituximab therapy for refractory antineutrophil cytoplasmic antibody-associated vasculitis Extract PDF direct |
Journal article, free access |
GET 2009. Rituximab as rescue therapy in anti-neutrophil cytoplasmic antibody-associated vasculitis: a single-centre experience with 15 patients Extract PDF direct |
??Schöhermarck ar 2014??
Journal article, free access |
GET 2015. Rituximab versus cyclophosphamide for ANCA-associated vasculitis with renal involvement Extract PDF direct |
??DMW 2014 mossig nicht im pm??
Journal article, free access |
GET 2014. Serum immunoglobulin levels and risk factors for hypogammaglobulinaemia during long-term maintenance therapy with rituximab in patients with granulomatosis with polyangiitis Extract PDF direct |
Journal article, free access |
GET 2013. Plasma exchange and glucocorticoid dosing in the treatment of anti-neutrophil cytoplasm antibody associated vasculitis (PEXIVAS): protocol for a randomized controlled trial Extract PDF direct |
Journal article, free access |
GET 2014. Rituximab in the treatment of anti-neutrophil cytoplasm antibody-associated vasculitis Extract PDF direct |
Journal article, free access |
GET 2015. Role of therapeutic plasmapheresis in ANCA-associated vasculitis Extract PDF direct |
Journal article, free access |
GET 2013. Efficacy of remission-induction regimens for ANCA-associated vasculitis Extract PDF direct |
Journal article, free access |
GET 2013. Induction regimens for ANCA-Associated Vasculitis Extract PDF direct |
Journal article, free access |
GET 2015. Outcomes of nonsevere relapses in antineutrophil cytoplasmic antibody-associated vasculitis treated with glucocorticoids Extract PDF direct |
(( This article reviews 9 challenging vasculitis mimickers: fibromuscular dysplasia, calciphylaxis, segmental arterial mediolysis, antiphospholipid syndrome, hypereosinophilic syndrome, lymphomatoid granulomatosis, malignant atrophic papulosis, livedoid vasculopathy, and immunoglobulin G4-related disease.))
??ar 2012 carh cebae?????
Journal article, free access |
GET 2012. Rituximab for remission maintenance in relapsing antineutrophil cytoplasmic antibody-associated vasculitis Extract PDF direct |
für hopn - scleroderm:
Journal article, free access |
GET 2012. Timing of transition between capillaroscopic patterns in systemic sclerosis Extract PDF direct |
??ard 2015 yusof??
Aktuelle Daten zur Erhaltungstherapie ANCA-assoziierter Vaskulitiden
Journal article, free access |
GET 2008. Outcomes from studies of antineutrophil cytoplasm antibody associated vasculitis: a systematic review by the European League Against Rheumatism systemic vasculitis task force Extract PDF direct |
Journal article, free access |
GET 2007. EULAR recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-associated vasculitis Extract PDF direct |
Journal article, free access |
GET 2007. Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies Extract PDF direct |
Journal article, free access |
GET 2014. Long-term follow-up of cyclophosphamide compared with azathioprine for initial maintenance therapy in ANCA-associated vasculitis Extract PDF direct |
Journal Paper, restricted access |
GET 2013. Maintenance of clinical remission in ANCA-associated vasculitis Extract PDF direct |
Journal article, free access |
GET 2012. Risk factors for relapse of antineutrophil cytoplasmic antibody-associated vasculitis Extract PDF direct |
??rheumatology 2010 despujol??
Journal article, free access |
GET 2008. Predictors of treatment resistance and relapse in antineutrophil cytoplasmic antibody-associated small-vessel vasculitis: comparison of two independent cohorts Extract PDF direct |
Journal Paper, restricted access |
GET 2005. Predictors of relapse and treatment resistance in antineutrophil cytoplasmic antibody-associated small-vessel vasculitis Extract PDF direct |
Journal Paper, restricted access |
GET 2003. Outcome of ANCA-associated renal vasculitis: a 5-year retrospective study Extract PDF direct |
Journal Paper, restricted access |
GET 2005. Predictors of relapse and treatment resistance in antineutrophil cytoplasmic antibody-associated small-vessel vasculitis Extract PDF direct |
??author?j... nejm 2003
Journal article, free access |
GET 2014. Granulomatosis with polyangiitis (Wegener s): impact of maintenance therapy duration Extract PDF direct |
Journal article, free access |
GET 2013. Efficacy of remission-induction regimens for ANCA-associated vasculitis Extract PDF direct |
Journal article, free access |
GET 2013. Induction regimens for ANCA-Associated Vasculitis Extract PDF direct |
Journal Paper, restricted access |
GET 2015. Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis: 2-year results of a randomised trial Extract PDF direct |
Journal article, free access |
GET 2015. Rituximab as an immunosuppressant in antineutrophil cytoplasmic antibody-associated vasculitis Extract PDF direct |
??ar 2014 azar?
Journal article, free access |
GET 2014. Rituximab versus azathioprine for maintenance in ANCA-associated vasculitis Extract PDF direct |
Journal article, free access |
GET 2015. Long-term follow-up of patients who received repeat-dose rituximab as maintenance therapy for ANCA-associated vasculitis Extract PDF direct |
??yusuf ard 2015 gbt es nicht??
Journal article, free access |
GET 2015. Maintenance therapy in antineutrophil cytoplasmic antibody-associated vasculitis: who needs what and for how long? Extract PDF direct |
Journal article, free access |
GET 2014. BSR and BHPR guideline for the management of adults with ANCA-associated vasculitis Extract PDF direct |
Journal article, free access |
GET 2014. Systemic rheumatoid vasculitis in the era of modern immunosuppressive therapy Extract PDF direct |
??ndt 2015 kronbille??
??ro 2013 benardi??
Journal article, free access |
GET 2015. Understanding the role of rituximab in ANCA GN: regressing toward the mean Extract PDF direct |
Journal Paper, restricted access |
GET 2014. Rituximab for induction and maintenance therapy in granulomatosis with polyangiitis (Wegener s) Results of a single-center cohort study on 66 patients Extract PDF direct |